EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Iraqi Registry Data Proves Safety and Efficacy of switching to Adalimumab Biosimilar in Treating Rheumatoid Arthritis

Yasameen Abbas, Nabaa Ihsan, Asal Adnan, Marwa Moayad, Ali AlKazzaz, Avin Maroof, Ali Abdulrahman, Nazar Abdulateef, Mohammad AlOsami, Faiq Gorial, Mohammed Altahhan, Zahraa Almansi und 1 weitere

AL-Kindy College Medical Journal · 2024

DOI: 10.47723/2km3dk27 ↗

Kurz gefasst

Fachartikel in der Zeitschrift AL-Kindy College Medical Journal, 2024. Verfasst von Yasameen Abbas und 12 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Adalimumab is approved for Rheumatoid Arthritis (RA). In 2021, A biosimilar (ABP501;Amgevita®) was licensed in Iraq. The current study aimed to ensure safety and Efficacy of Amgevita in RA Patients in Iraq. Patients and Methods: A Cross sectional Observational study Started on 69 RA Records receiving Amgevita. Data collected from local registry then examined for disease activity and adverse reactions for 9 months follow up.

Results

Thirty patients completed the 9 months period of the study: aged (49±14) years; 77.5% females. After 3, 6 and 9 months of follow up, patients' mean (SD) CDAI 27.8 ( 13.60 ) which was statistically lower (19.80) (6.96), 17.70 (2.790), and 19 (1.040), p

Zitieren

APA

Abbas, Y., Ihsan, N., Adnan, A., Moayad, M., AlKazzaz, A., Maroof, A., Abdulrahman, A., Abdulateef, N., AlOsami, M., Gorial, F., Altahhan, M., Almansi, Z., & Alnoori, A. (2024). Iraqi Registry Data Proves Safety and Efficacy of switching to Adalimumab Biosimilar in Treating Rheumatoid Arthritis. AL-Kindy College Medical Journal. https://doi.org/10.47723/2km3dk27

Vancouver

Abbas Y, Ihsan N, Adnan A, Moayad M, AlKazzaz A, Maroof A, et al. Iraqi Registry Data Proves Safety and Efficacy of switching to Adalimumab Biosimilar in Treating Rheumatoid Arthritis. AL-Kindy College Medical Journal. 2024. doi:10.47723/2km3dk27

BibTeX
@article{Abbas2024,
  author = {Abbas, Yasameen and Ihsan, Nabaa and Adnan, Asal and Moayad, Marwa and AlKazzaz, Ali and Maroof, Avin and Abdulrahman, Ali and Abdulateef, Nazar and AlOsami, Mohammad and Gorial, Faiq and Altahhan, Mohammed and Almansi, Zahraa and Alnoori, Ali},
  title = {Iraqi Registry Data Proves Safety and Efficacy of switching to Adalimumab Biosimilar in Treating Rheumatoid Arthritis},
  journal = {AL-Kindy College Medical Journal},
  year = {2024},
  doi = {10.47723/2km3dk27}
}
Kostenlos starten →